Stockscreener 앱 받기
28.37
6.69%
1.78
시간 외 거래:
28.35
-0.02
-0.07%
전일 마감가:
$26.59
열려 있는:
$27.87
하루 거래량:
2.45M
Relative Volume:
1.51
시가총액:
$4.80B
수익:
$1.51B
순이익/손실:
$333.35M
주가수익비율:
22.88
EPS:
1.24
순현금흐름:
$315.22M
1주 성능:
+7.30%
1개월 성능:
-2.07%
6개월 성능:
+17.96%
1년 성능:
+14.44%
1일 변동 폭
$27.29
$28.46
1주일 범위
$25.67
$28.46
52주 변동 폭
$22.06
$32.88
Alkermes Plc Stock (ALKS) Company Profile
명칭
Alkermes Plc
전화
00-353-1-772-8000
주소
CONNAUGHT HOUSE, DUBLIN 4
Alkermes Plc Stock (ALKS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-11-20 | 재개 | JP Morgan | Neutral |
| 2023-10-24 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-10-17 | 개시 | UBS | Neutral |
| 2022-11-03 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2022-10-14 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-08-16 | 개시 | Piper Sandler | Neutral |
| 2022-04-22 | 재개 | Goldman | Buy |
| 2022-04-20 | 개시 | Goldman | Buy |
| 2022-01-27 | 업그레이드 | Cantor Fitzgerald | Hold → Overweight |
| 2021-12-01 | 개시 | Citigroup | Neutral |
| 2021-10-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-09-02 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2020-10-15 | 업그레이드 | Mizuho | Neutral → Buy |
| 2020-07-30 | 다운그레이드 | Goldman | Neutral → Sell |
| 2020-02-14 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2020-02-14 | 재확인 | H.C. Wainwright | Neutral |
| 2020-02-14 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2020-02-06 | 개시 | Mizuho | Neutral |
| 2020-01-31 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2019-09-05 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2019-07-15 | 업그레이드 | Goldman | Sell → Neutral |
| 2019-05-31 | 개시 | H.C. Wainwright | Neutral |
| 2019-05-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2018-12-19 | 다운그레이드 | Goldman | Neutral → Sell |
| 2018-12-14 | 개시 | Wolfe Research | Underperform |
| 2018-12-13 | 다운그레이드 | Credit Suisse | Outperform → Underperform |
| 2018-11-05 | 개시 | Piper Jaffray | Neutral |
| 2018-08-07 | 개시 | Stifel | Hold |
| 2018-06-21 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-06-06 | 개시 | B. Riley FBR, Inc. | Buy |
| 2018-05-16 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-05-11 | 개시 | BofA/Merrill | Buy |
모두보기
Alkermes Plc 주식(ALKS)의 최신 뉴스
Vanguard Group Inc's Recent Transaction in Alkermes PLC Shares - GuruFocus.com
Alkermes (NASDAQ:ALKS) Shares Gap UpTime to Buy? - MarketBeat
Alkermes raised to buy by Stifel on increased confidence for ALKS2680 - MSN
Alkermes raised to buy by Stifel on increased confidence for ALKS2680 (NASDAQ:ALKS) - Seeking Alpha
Alkermes (NASDAQ:ALKS) Upgraded by Stifel Nicolaus to Buy Rating - MarketBeat
A Glimpse Into The Expert Outlook On Alkermes Through 9 Analysts - Benzinga
Stifel raises Alkermes target to $36, upgrades to buy By Investing.com - Investing.com Australia
Stifel raises Alkermes target to $36, upgrades to buy - Investing.com India
DekaBank Deutsche Girozentrale Lowers Stock Holdings in Alkermes plc (NASDAQ:ALKS) - MarketBeat
(ALKS) Proactive Strategies - Stock Traders Daily
Short Interest in Alkermes plc (NASDAQ:ALKS) Drops By 7.9% - MarketBeat
Alkermes plc (NASDAQ:ALKS) Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Alkermes holds steady stock target with neutral rating amid royalty segment dip - Investing.com
Alkermes holds steady stock target with neutral rating amid royalty segment dip By Investing.com - Investing.com South Africa
Alkermes's SWOT analysis: innovative pipeline drives CNS stock's future - Investing.com
Alkermes Eyes Completion of Phase 2 Narcolepsy Studies in 2025 - Sleep Review
Goldman Sachs keeps Alkermes stock buy-rated ahead of milestone readouts, trims PT - Investing.com Canada
Piper Sandler cuts Alkermes stock target, keeps Overweight rating By Investing.com - Investing.com Australia
Leerink maintains Alkermes stock rating with $28 target amid financial projections - Investing.com Australia
Leerink maintains Alkermes stock rating with $28 target amid financial projections By Investing.com - Investing.com South Africa
Alkermes (NASDAQ:ALKS) PT Lowered to $30.00 - MarketBeat
Piper Sandler cuts Alkermes stock target, keeps Overweight rating - Investing.com
Alkermes' Q3 Earnings & Revenues Fall Shy of Estimates, Stock Down - MSN
Alkermes' Q3 Earnings & Revenues Fall Shy Of Estimates, Stock Down - Barchart
Alkermes' (ALKS) Overweight Rating Reiterated at Piper Sandler - MarketBeat
Alkermes plc (NASDAQ:ALKS) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Alkermes Plc reports solid Q3 growth, eyes future expansion - Investing.com
Alkermes Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
Alkermes PLC (ALKS) Q3 2024 Earnings Call Highlights: Strong Pro - GuruFocus.com
Substance Abuse Treatment Market to Witness Massive Growth (2024-2031)| Allergan PLC, Alkermes, Noramco. - openPR
Alkermes PLC (ALKS) Q3 2024 Earnings Call Highlights: Strong Proprietary Product Growth and ... - Yahoo Finance
Alkermes: Q3 Earnings Snapshot - mySA
Alkermes' Q3 Proprietary Sales Soar 18% - The Motley Fool
Alkermes (NASDAQ:ALKS) Shares Gap DownHere's Why - MarketBeat
Moody Aldrich Partners LLC Has $2.38 Million Stock Position in Alkermes plc (NASDAQ:ALKS) - MarketBeat
Alkermes (ALKS) Reports Q3 Earnings: What Key Metrics Have to Say - Yahoo Finance
Alkermes plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Fetal Alcohol Spectrum Disorder Treatment Market Overall Study - openPR
Alkermes PLC Q3 2024 Earnings: EPS of $0.56 Beats Estimates, Rev - GuruFocus.com
Alkermes (NASDAQ:ALKS) Updates FY 2024 Earnings Guidance - MarketBeat
Alkermes (ALKS) Lags Q3 Earnings and Revenue Estimates - Yahoo Finance
Alkermes plc Reports Third Quarter 2024 Financial Results - PR Newswire
Alkermes' SWOT analysis: undervalued neuro-innovator stock faces pivotal phase - Investing.com
Alkermes's Earnings: A Preview - Benzinga
Alkermes PLC (ALKS) Q3 2024 Earnings Report Preview: What to Exp - GuruFocus.com
Alkermes (ALKS) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures - Yahoo Finance
Alkermes plc (NASDAQ:ALKS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Alkermes plc (NASDAQ:ALKS) Stock Holdings Increased by Vontobel Holding Ltd. - MarketBeat
Learn to Evaluate (ALKS) using the Charts - Stock Traders Daily
ALKSAlkermes Inc. plc Latest Stock News & Market Updates - StockTitan
Alkermes (ALKS) to Release Quarterly Earnings on Thursday - MarketBeat
Alkermes Plc (ALKS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Alkermes Plc 주식 (ALKS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Parisi Samuel Joseph | VP, Finance (Interim PAO) |
Feb 27 '24 |
Sale |
29.65 |
2,559 |
75,874 |
7,717 |
| LAURENCIN CATO T | Director |
Feb 15 '24 |
Option Exercise |
22.52 |
2,690 |
60,579 |
17,859 |
| LAURENCIN CATO T | Director |
Feb 15 '24 |
Sale |
31.85 |
2,690 |
85,676 |
15,169 |
0.88%
0.42%
자본화:
|
볼륨(24시간):